BIOMAT Database Logo BIOMAT Database Logo

Serum tryptophan, kynurenine, and neopterin in patients with Guillain-Barre-syndrome (GBS) and multiple sclerosis (MS). 1996

V Rudzite, and J Berzinsh, and I Grivane, and D Fuchs, and G Baier-Bitterlich, and H Wachter
Laboratory of Biochemistry, Latvia Institute of Cardiology, Riga, Latvia.

UI MeSH Term Description Entries
D007737 Kynurenine A metabolite of the essential amino acid tryptophan metabolized via the tryptophan-kynurenine pathway.
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D011129 Polyradiculoneuropathy Diseases characterized by injury or dysfunction involving multiple peripheral nerves and nerve roots. The process may primarily affect myelin or nerve axons. Two of the more common demyelinating forms are acute inflammatory polyradiculopathy (GUILLAIN-BARRE SYNDROME) and POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING. Polyradiculoneuritis refers to inflammation of multiple peripheral nerves and spinal nerve roots. Autoimmune Demyelinating Disease, Peripheral,Demyelinating Autoimmune Disease, Peripheral,Demyelinating Disease, Peripheral Autoimmune,Peripheral Autoimmune Demyelinating Disease,Polyradiculoneuritis,Polyradiculoneuritides,Polyradiculoneuropathies
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001708 Biopterins Pterin derivatives based on 2-amino-6-(1,2-dihydroxypropyl)-4(1H)-pteridinone. Biopterins are natural products that have been considered as growth factors for some insects. Biopterins are cofactors for the AROMATIC AMINO ACID hydroxylases and NITRIC OXIDE SYNTHASE. Deficiencies in BIOPTERINS metabolism (e.g., lowered TETRAHYDROBIOPTERIN) are associated with neurological deterioration (e.g., HYPERPHENYLALANINAEMIA). 2-Amino-6-((1S,2R)-1,2-dihydroxypropyl)-4(1H)-pteridinone,2-Amino-6-((1S,2S)-1,2-dihydroxypropyl)-4(1H)-pteridinone,2-Amino-6-(1,2-dihydroxypropyl)-4(8H)-pteridinone,2-amino-6-((1R,2R)-1,2-dihydroxypropyl)-4(3H)-pteridinone,4(1H)-Pteridinone, 2-amino-6-(1,2-dihydroxypropyl)-, (S-(R*,S*))-,6-Biopterin,Biopterin,D-threo-Biopterin,L-Biopterin,L-erythro-Biopterin,L-threo-Biopterin,2-Amino-6-(1,2-dihydroxypropyl)-4(1H)-pteridinone,Dictyopterin,Orinapterin,6 Biopterin,D threo Biopterin,L Biopterin,L erythro Biopterin,L threo Biopterin
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014364 Tryptophan An essential amino acid that is necessary for normal growth in infants and for NITROGEN balance in adults. It is a precursor of INDOLE ALKALOIDS in plants. It is a precursor of SEROTONIN (hence its use as an antidepressant and sleep aid). It can be a precursor to NIACIN, albeit inefficiently, in mammals. Ardeydorm,Ardeytropin,L-Tryptophan,L-Tryptophan-ratiopharm,Levotryptophan,Lyphan,Naturruhe,Optimax,PMS-Tryptophan,Trofan,Tryptacin,Tryptan,Tryptophan Metabolism Alterations,ratio-Tryptophan,L Tryptophan,L Tryptophan ratiopharm,PMS Tryptophan,ratio Tryptophan
D019798 Neopterin A pteridine derivative present in body fluids; elevated levels result from immune system activation, malignant disease, allograft rejection, and viral infections. (From Stedman, 26th ed) Neopterin also serves as a precursor in the biosynthesis of BIOPTERINS. 2-Amino-6-(1,2,3-trihydroxypropyl)-4(3H)-pteridinone,Monapterin,Neopterin, (R*, R*)-Isomer,Neopterin, (erythro-D)-Isomer,Neopterin, (erythro-L)-Isomer,Neopterin, (threo-D)-Isomer,Neopterin, (threo-L)-Isomer,Umanopterin

Related Publications

V Rudzite, and J Berzinsh, and I Grivane, and D Fuchs, and G Baier-Bitterlich, and H Wachter
Fatal Guillain-Barre Syndrome (GBS) in Dengue.
June 2015, The Journal of the Association of Physicians of India,
V Rudzite, and J Berzinsh, and I Grivane, and D Fuchs, and G Baier-Bitterlich, and H Wachter
Serum Neopterin, Biopterin, Tryptophan, and Kynurenine Levels in Patients with Fabry Disease.
January 2024, Balkan medical journal,
V Rudzite, and J Berzinsh, and I Grivane, and D Fuchs, and G Baier-Bitterlich, and H Wachter
Serum and cerebrospinal fluid antioxidant activity and lipid peroxidation in Guillain-Barre syndrome and multiple sclerosis patients.
April 2010, The International journal of neuroscience,
V Rudzite, and J Berzinsh, and I Grivane, and D Fuchs, and G Baier-Bitterlich, and H Wachter
Serum Inflammatory Markers in Patients with Guillain Barre Syndrome.
January 2022, Neurology India,
V Rudzite, and J Berzinsh, and I Grivane, and D Fuchs, and G Baier-Bitterlich, and H Wachter
Evaluation of Post Guillain-Barre Syndrome (GBS) Patients: A Cross Sectional Study.
April 2019, Mymensingh medical journal : MMJ,
V Rudzite, and J Berzinsh, and I Grivane, and D Fuchs, and G Baier-Bitterlich, and H Wachter
Unilateral facial palsy in Guillain-Barre syndrome (GBS): a rare occurrence.
October 2012, BMJ case reports,
V Rudzite, and J Berzinsh, and I Grivane, and D Fuchs, and G Baier-Bitterlich, and H Wachter
SARS-CoV-2 and Guillain-Barre Syndrome (GBS): Insights from ASIA Perspectives.
January 2021, Annals of Indian Academy of Neurology,
V Rudzite, and J Berzinsh, and I Grivane, and D Fuchs, and G Baier-Bitterlich, and H Wachter
Serum kynurenine and neopterin concentrations in patients with cardiomyopathy.
April 1992, Immunology letters,
V Rudzite, and J Berzinsh, and I Grivane, and D Fuchs, and G Baier-Bitterlich, and H Wachter
[Pathologic studies of Guillain-Barre syndrome (GBS) and 13 rabbits with experimental allergic neuritis].
June 1990, Zhonghua shen jing jing shen ke za zhi = Chinese journal of neurology and psychiatry,
V Rudzite, and J Berzinsh, and I Grivane, and D Fuchs, and G Baier-Bitterlich, and H Wachter
Clinico-electrophysiological profile and predictors of functional outcome in Guillain-Barre syndrome (GBS).
December 2013, Journal of the neurological sciences,
Copied contents to your clipboard!